 Home > Medical News > Latest Medical News > The U.S. FDA approves an innovative oral compound drug for the treatment of schizophrenia and bipolar I disorder

The U.S. FDA approves an innovative oral compound drug for the treatment of schizophrenia and bipolar I disorder

 Last Update: 2021-06-04
 Source: Internet
 Author: User

Tags

2 3 pentanedione

oai fda

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On June 1, 2021, Alkermes announced that the US FDA has approved its new drug Lybalvi (formerly known as ALKS 3831) for the treatment of adult schizophrenia and bipolar I disorder.

Olanzapine is a psychiatric drug that has been marketed, but one of its main side effects is that it will significantly increase the weight of patients, thereby increasing their risk of other metabolic diseases.

▲The role of Lybalvi (picture source: Alkermes official website)

In the clinical development project of the drug ENLIGHTEN, Lybalvi proved its good effectiveness, safety and tolerability as an antipsychotic.

▲Lybalvi significantly reduced the weight gain of patients in the ENLIGHTEN-2 clinical trial (picture source: Alkermes official website)

Bipolar disorder is a disease that can cause severe fluctuations in mood, vitality, and ability to perform daily tasks.

Note: The original text has been deleted

Reference materials:

[1] Alkermes Announces FDA Approval of LYBALVI™ for the Treatment of Schizophrenia and Bipolar I Disorder.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.